Zosano Pharma Stock News

Healthcare > Biotechnology

Buy ZSAN

*Your capital is at risk

$0.110

-0.0088 (-7.40%)

At Close: Sep 27, 2022

ZSAN CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Zosano Pharma Corporation

07:51pm, Thursday, 29'th Oct 2020

LOS ANGELES--(BUSINESS WIRE)---- $ZSAN #CLASSACTION--ZSAN CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Zosano Pharma Corporation

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by